← Back to headlines
Merck & Co. Advances on Strong Keytruda Sales and Positive Clinical Trials
Merck & Co. saw its stock advance, driven by robust sales of its drug Keytruda and favorable results from recent clinical trials.
18 Feb, 15:17 — 18 Feb, 15:17
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Daily wage increase for minimum wage earners in Davao Region
just now
Bureau of Customs Auctions More Discaya Luxury Vehicles for P25.7 Million
just now
Lithuanian Tax Authorities Focus on Online Income from Platforms like Vinted and Wolt
8m ago
Seb Group Plans 2100 Job Cuts Globally, 500 in France
10m ago